Skip to main content
Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

Apo-Divalproex

Covered
  • Active ingredient(s):
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    • Enteric Tablet 125 mg DIN : 2239698
    • Enteric Tablet 250 mg DIN : 2239699
    • Enteric Tablet 500 mg DIN : 2239700

Epival 125

Covered
  • Active ingredient(s):
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Enteric Tablet 125 mg DIN : 596418

Mylan-Divalproex

Covered
  • Active ingredient(s):
  • Manufactured by:
    Mylan Pharmaceuticals ULC (Mylan)
  • Strength and dosage form:
    • Enteric Tablet 125 mg DIN : 2458926
    • Enteric Tablet 250 mg DIN : 2458934
    • Enteric Tablet 500 mg DIN : 2459019

Epival 250

Covered
  • Active ingredient(s):
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Enteric Tablet 250 mg DIN : 596426

Epival 500

Covered
  • Active ingredient(s):
  • Manufactured by:
    BGP Pharma ULC (BGP Pharma)
  • Strength and dosage form:
    Enteric Tablet 500 mg DIN : 596434

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.